Doctor profile · Federal record
Dr. Sarah McGinty, M.D.
Dermatology Physician (CMS: Dermatology) · Baton Rouge, LA
- NPI 1164841243
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 12 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
10154 Jefferson Hwy
Baton Rouge, LA 70809
(225) 927-5663
fax (225) 928-7341
Credentials & registration
- NPI registered
- April 2014 — 12 yrs on file
- Profile last updated
- August 16, 2018
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Louisiana #308558
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164841243. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,075
Distinct HCPCS
10
Medicare allowed
$48,683
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 464 | 63 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 145 | 113 | $84 | |
17000 |
Destruction of precancer skin growth, 1 growth | 96 | 75 | $48 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 79 | 64 | $53 | |
11102 |
Biopsy of related skin growth, first growth | 60 | 55 | $86 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 39 | 39 | $104 | |
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 32 | 22 | $31 | |
11103 |
Biopsy of related skin growth, each additional growth | 30 | 18 | $44 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 30 | 21 | $155 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 27 | 27 | $67 |
In context: peer comparison
Among 15 peers in this city , average services per provider: 254. This provider delivers 4.2× the peer median.Open Payments
Industry payments received
All-time total
$3,504
Transactions
188
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 31 | $440.64 | |
| GENZYME CORPORATION | 14 | $397.93 | |
| Lilly USA, LLC | 16 | $389.55 | |
| Incyte Corporation | 17 | $325.57 | |
| Janssen Biotech, Inc. | 12 | $278.50 | |
| Regeneron Healthcare Solutions, Inc. | 11 | $250.16 | |
| PFIZER INC. | 19 | $235.28 | |
| UCB, Inc. | 12 | $185.46 | |
| Amgen Inc. | 8 | $159.17 | |
| LEO Pharma Inc. | 18 | $156.01 | |
| Galderma Laboratories, L.P. | 10 | $147.44 | |
| Arcutis Biotherapeutics, Inc. | 8 | $139.31 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98.67 | |
| Novartis Pharmaceuticals Corporation | 3 | $72.26 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $61.85 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,015
Patients
524
Total drug cost
$433,040
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 147 | 73 | $3,158 |
| Clobetasol Propionate | Generic | 146 | 74 | $6,013 |
| Triamcinolone Acetonide | Generic | 144 | 95 | $1,257 |
| Mupirocin | Generic | 111 | 76 | $870 |
| Doxycycline Hyclate | Generic | 81 | 53 | $1,362 |
| Dupixent Pen (Dupilumab) | Brand | 78 | 11 | $296,689 |
| Hydrocortisone | Generic | 55 | 42 | $593 |
| Clindamycin Phosphate | Generic | 50 | 22 | $1,390 |
| Hydroxyzine Hcl | Generic | 45 | 24 | $451 |
| Finasteride | Generic | 33 | 11 | $187 |
Frequently asked questions
What is Dr. Sarah McGinty's medical specialty?
Dr. Sarah McGinty practices Dermatology Physician in Baton Rouge, LA.
Where does Dr. Sarah McGinty practice?
Dr. Sarah McGinty practices at 10154 Jefferson Hwy, Baton Rouge, LA 70809. Office phone: 2259275663.
What is Dr. Sarah McGinty's NPI?
Dr. Sarah McGinty's National Provider Identifier (NPI) is 1164841243, issued by NPPES.
Does Dr. Sarah McGinty accept Medicare assignment?
Yes. Dr. Sarah McGinty accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sarah McGinty commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.